BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 3, 2011
View Archived Issues
Summit presents preclinical data on antimicrobial agents targeting CDI
Read More
Final first-in-human data presented on CureVac's prostate cancer mRNA vaccine
Read More
Horizon Pharma submits NDA for Lodotra to FDA
Read More
BioDelivery Sciences reports preliminary data from BEMA Buprenorphine trial
Read More
Canadian university discloses novel Abeta-targeted antibodies
Read More
Amira Pharmaceuticals patents new 5-LO inhibitors
Read More
Advanced Cell Technology receives approval to treat more patients in two U.S. stem cell trials
Read More
Scientists identify SNP associated with increased susceptibility to bacterial meningitis
Read More
Bacterial DNA minor groove binder shows promise against CDI-associated diarrhea
Read More
Eisai evaluates new anticoagulants in human microdosing study
Read More
Japanese Pharmaceutical Affairs Subcommittee reviews Chugai's application for Epogin
Read More
Dosing begins in Trius' phase III TR701-113 trial
Read More
FDA reviews safety of drospirenone-containing birth control pills
Read More
Novel anticancer derivatives presented
Read More
Boehringer Ingelheim Pharma claims new therapeutics targeting amyloid beta
Read More
GlaxoSmithKline reports new SAP-binding proteins
Read More
Pharmaxis completes enrollment in phase II ASM-8 trial
Read More
Durata Therapeutics begins enrollment in second pivotal dalbavancin trial
Read More
Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma
Read More
Proteonomix continues preparations for clinical trial of stem cell treatment for ESLD
Read More
Almirall launches Libertek in Spain
Read More
Microbicide Trials Network to discontinue use of tenofovir tablets in HIV prevention study
Read More
Baxter files MAA with EMA for investigational Ig therapy
Read More
Formal Medicare coverage policy established for Genomic Health's Oncotype DX colon cancer test
Read More
Takeda completes Nycomed acquisition
Read More